HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Study of the squamous cell carcinoma (SCC) antigen in benign diseases].

AbstractBACKGROUND:
The values of the squamous cell carcinoma (SCC) antigen in benign diseases were studied with the aim of determining false positive values in the study of epidermoid carcinomas.
METHODS:
Serum determinations of the SCC antigen were performed by radioimmunoanalysis with the Abbott SCC-RIA kit. The control group was made up of a total of 719 subjects of whom 317 were healthy blood donors and 402 were healthy women with normal cervicovaginal cytology. The study group was made up of 693 women with benign diseases.
RESULTS:
Ninety-eight point two percent of the subjects from the control group presented values under 2.5 ng/ml, therefore this value was chosen as the maximum limit of normality. Higher values than this threshold of normality were observed in 11.7% of the 34 patients with chronic disease (0.1-18.2 ng/ml) and in 57.5% of the 40 patients with chronic renal failure (0.5-6.0 ng/ml).
CONCLUSIONS:
In patients with chronic liver disease or chronic renal failure, the serum determination of the squamous cell carcinoma antigen loses its value as a tumor marker of epidermoid carcinomas given the risk of obtaining false positive values.
AuthorsJ M Gris, J Xercavins, L Trillo, G Encabo
JournalMedicina clinica (Med Clin (Barc)) Vol. 106 Issue 6 Pg. 205-8 (Feb 17 1996) ISSN: 0025-7753 [Print] Spain
Vernacular TitleEstudio del antígeno del carcinoma de células escamosas (scc) en las enfermedades benignas.
PMID8667660 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Biomarkers, Tumor
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm (analysis)
  • Biomarkers, Tumor
  • Blood Donors
  • Carcinoma, Squamous Cell (immunology)
  • Chronic Disease
  • False Positive Reactions
  • Female
  • Humans
  • Kidney Failure, Chronic (immunology)
  • Liver Diseases (immunology)
  • Male
  • Middle Aged
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: